Biotechnology Stocks May Begin to Outperform the Broader Market Soon

  • 📰 Investingcom
  • ⏱ Reading Time:
  • 64 sec. here
  • 4 min. at publisher
  • 📊 Quality Score:
  • News: 32%
  • Publisher: 53%

S&P 500 News

Ishares Biotechnology ETF

Stocks Analysis by Michele Schneider covering: S&P 500, iShares Biotechnology ETF. Read Michele Schneider's latest article on Investing.com

“IBB sits just below the 200-WMA. Plus, he is in the middle of the weekly channel range. Furthermore, back in May, IBB handily cleared above the 50-WMA.Now, we give it fresh eyes to see what should happen next so that this is not a one-day wonder.If IBB can clear that level, it will go to a new multiyear high as this has underperformed the benchmark since late 2021.If we move out in time frame, the weekly chart also tells us a story.

Should IBB hold over 140 as the week and end of the month progresses, we see a potential $20 move up from here.This is all risk on-as long as it holds above 76.50Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors.

Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.would like to remind you that the data contained in this website is not necessarily real-time nor accurate.

It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Source: News Formal (newsformal.com)

Ishares Biotechnology ETF

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 450. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

USD/CHF: Did the Swiss Franc Whisper Its Next Move?Stocks Analysis by Michele Schneider covering: USD/CHF, Invesco CurrencyShares® Swiss Franc Trust. Read Michele Schneider's latest article on Investing.com
Source: Investingcom - 🏆 450. / 53 Read more »

2 Stocks That Could Create a Trading Opportunity SoonStocks Analysis by Michele Schneider covering: NYSE TOP US 100, Coty Inc. Read Michele Schneider's latest article on Investing.com
Source: Investingcom - 🏆 450. / 53 Read more »

Hospital fundraiser pulls Rob Schneider mid-act after horrified realization that they booked Rob Schneider'We do not condone, accept, endorse, or share Mr. Schneider’s positions'
Source: TheAVClub - 🏆 340. / 59 Read more »

Semiconductors Shine, But Outlook for Other Sectors Remains MixedStocks Analysis by Michele Schneider covering: US Small Cap 2000, iShares Biotechnology ETF, NVIDIA Corporation, Target Corporation. Read Michele Schneider's latest article on Investing.com
Source: Investingcom - 🏆 450. / 53 Read more »

What Unties the Market’s Gordian Knot?Market Overview Analysis by Michele Schneider covering: . Read Michele Schneider's latest article on Investing.com
Source: Investingcom - 🏆 450. / 53 Read more »

Long Bonds Approach Key Resistance: A Breakout Here Should Be ConcerningMarket Overview Analysis by Michele Schneider covering: XAU/USD, XAG/USD, S&P 500, Gold Futures. Read Michele Schneider's latest article on Investing.com
Source: Investingcom - 🏆 450. / 53 Read more »